Sun, Dec 28, 2014, 6:10 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cleantech Solutions International, Inc. Message Board

rchites 1077 posts  |  Last Activity: 19 hours ago Member since: Apr 12, 2004
  • Reply to

    BUFFET GAVE 2.1 BILLION

    by rchites Dec 11, 2014 6:21 AM
    rchites rchites Dec 11, 2014 8:52 AM Flag

    It came across the local news station that he gave GATES the money.... Its just for the general Bill and Melissa foundation...... I am sure some of the money will go into vaccines and disease cures... Not only Ebola but for many of their causes.
    Warren Buffett donates USD 2.1 billion to charity, largest in 2014

    PTI New Delhi Last Updated: December 10, 2014 | 17:22 IST

  • To the Gates foundation. Shorts are dead meat......................................BILL has the money ! More Vaccines!

  • this was a good week.

  • Reply to

    Reached stability, and PPS slightly increasing,

    by wallstreet69s Dec 10, 2014 11:06 AM
    rchites rchites Dec 10, 2014 1:08 PM Flag

    As a general rule big funds do not buy under 5 dollars. Many small cap and penny stock funds can buy. If you go to the Wallstreet Journal and put in a IBIO you will see many funds are adding IBIO regardless of what is normal.

  • Reply to

    Reached stability, and PPS slightly increasing,

    by wallstreet69s Dec 10, 2014 11:06 AM
    rchites rchites Dec 10, 2014 1:05 PM Flag

    These institutions and Funds own shares. Many have been adding the last two months. You know about Aspire and Eastern Capital. Vanguard Extended Market Index Fund, Vanguard Total Stock Market Index Fund Vanguard Total Stock Market Index Fund Fidelity Spartan Extended Market Index Fund Vanguard Invt. Fds. ICVC - US Equity Index
    KCG Americas LLC
    Northern Trust Investments, Inc.
    G. W. Henssler & Associates Ltd.
    Millennium Management LLC
    SSgA Funds Management, Inc.
    Thompson, Davis & Co.
    UBS Financial Services, Inc.


    Vanguard Group Inc.
    991,217 $609 09/30/2014
    IBIO 991,217 $609 09/30/2014
    Geode Capital Management LLC
    342,667 $210 09/30/2014
    IBIO 342,667 $210 09/30/2014
    KCG Holdings Inc.
    97,702 $60 09/30/2014
    IBIO 97,702 $60 09/30/2014
    Northern Trust Corp
    38,976 $24 09/30/2014
    IBIO 38,976 $24 09/30/2014
    GW Henssler & Associates Ltd.
    17,500 $11 09/30/2014
    IBIO 17,500 $11 09/30/2014
    State Street Corp
    13,400 $8 09/30/2014
    IBIO 13,400 $8 09/30/2014
    Thompson Davis & CO. Inc.
    5,000 $3 09/30/2014
    IBIO 5,000 $3 09/30/2014
    UBS AG
    2,500 $2
    Its hard not to know about IBIO if you have studies Ebola or small cap biotech stocks.

  • Reply to

    Rally Is Over IMO

    by schinzo123 Dec 10, 2014 10:50 AM
    rchites rchites Dec 10, 2014 1:00 PM Flag

    What about the MAPP, ICON licensing? Kentucky and Amgen? BARDA news and Caliber could come any day. Better wipe off the crystal ball as it is no good. They have a big pipeline and a host of vaccines that could bring news. JAZZ or GSK could even buy them for the monoclonal antibodies . They saw the great White house news. The Funding could double this with contracts. Then their is NOVICCi that Mapp contacted..... news could be from a number of places.

  • Reply to

    iBIO news on the ways

    by befobell Dec 10, 2014 10:07 AM
    rchites rchites Dec 10, 2014 10:13 AM Flag

    schinzo in the psych ward claiming he created EBOLA

  • Reply to

    PR, all fluff, no substance

    by freetechme2 Dec 10, 2014 9:11 AM
    rchites rchites Dec 10, 2014 9:41 AM Flag

    the Whites house fact sheets and Directors testimony was just a confirmation IBIO was on the right track. That should have been the buy signal for you. Now we are sitting on a billions being distributed into EBOLA. This will hit DARPA ,BARTA , WHO, and be a liquidity wind fall for experimental companies that are leading the PACK!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

  • Reply to

    10am e.t. Today.....:)

    by goodbrain007 Dec 10, 2014 9:31 AM
    rchites rchites Dec 10, 2014 9:36 AM Flag

    IBIO-CFB03 to address significant unmet medical need for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis, and other fibrotic diseases.
    In addition to reviewing IBIO-CFB03, senior management will provide the following information to shareholders at the meeting:

    •Opportunities for vaccine and antibody products using the iBioLaunch platform. The efficiency and flexibility of iBioLaunch technology and the company's issued patent portfolio have attracted increasing commercial and scientific interest in light of serious challenges such as the Ebola virus disease outbreak in West Africa.

    •Opportunities for iBio's subsidiary operations and business relationships in Brazil. The iBioLaunch-based recombinant yellow fever vaccine continues development with collaborators in Brazil. Management will discuss previously announced product candidates under review for potential development for the Brazilian market.

    •Opportunities in Japan. iBio has extended business development activities into Japan in collaboration with Kanematsu Chemicals Corporation, and will discuss the company's general approach to developing opportunities in non-U.S. markets.

    •Programs involving government and NGO sponsorship. Phase 1 clinical trials of a malaria transmission-blocking vaccine and a hookworm vaccine are underway, both of which are non-commercial products fully funded by third parties. These and potential new programs provide valuable data on medically important applications of iBio's proprietary technology.

    Additionally, co announced several lead formulations are under evaluation for clinical development, and work necessary to file an investigational new drug application with the FDA is being conducted, a process the company expects to complete by mid-2015.
    •iBio has determined that preclinical efficacy results and lack of significant toxicity in experiments conducted to date justify high priority advancement of the product into clinical trials. The serious unmet

  • ALL HANDS ONM DECK_____________ that is a double for the companies leading the fight . The companies designed for out breaks . The ones that have improved plantibodies through out the years just waiting for this opportunity................. BINGO!

  • rchites by rchites Dec 10, 2014 9:15 AM Flag

    we could be a day away from a double. GOOD chances on a massive run to make this the stock of the year..... Many BIOTECH stocks double and triple and this has been set up to do it again. This time it will hold the PPS as people realize this is a game changer and disruptive stock. BIG PHARMA must act and GET IN THE GAME we are ticking down right now.................

  • http://news.yahoo.com/video/ebola-attacks-body-101524420.html

  • rchites rchites Dec 10, 2014 9:09 AM Flag

    MIDWEST JOBS best in years................ more forklifts and batteries needed. SANTA is coming!

  • Reply to

    Zacks Article On Market COnditions

    by justmeinvesting222 Dec 10, 2014 9:04 AM
    rchites rchites Dec 10, 2014 9:07 AM Flag

    FYI is this is another bull run starting for the next decade......... This temporary international problem bleeds green for the US stock market inflow.... The rust belt is hiring and expanding..... MORE JOBS in the last report confirm the up trend........ buy this as it is the future.... The PPS is the lowest in 10 months going into the bull Santa rally............. cover you foolish talk. USA RALLY in the making

  • this is a gift

  • Reply to

    bag holder

    by pat.tremblay Dec 9, 2014 6:30 PM
    rchites rchites Dec 10, 2014 8:35 AM Flag

    he is to stupid to understand the market potential.... it has to many zeros. the company web site is not that hard to find.

  • Reply to

    bag holder

    by pat.tremblay Dec 9, 2014 6:30 PM
    rchites rchites Dec 10, 2014 8:33 AM Flag

    we are back were we started before EBOLA. Looks like you are the braindead bashers that showed up after the run and fall..late to the game... ..You must be the unlucky twit that applies financials to a research and development company right after they developed their product and before sales/contracts.. the money has been spent and the product could be the future of cures and fast vaccines.... ... With out an epidemic most the defense stocks look bad as epidemics are a wind fall. . EITHER your a twit talking the stock down for a better deal or making 5 cents a post. Either way the short game is over here loosing the run back. this stock will do well with or with out Ebola.... only monkey brains don't do their DD and don't know that.

  • Reply to

    hey pat tremblay..

    by starteam003 Dec 9, 2014 10:02 PM
    rchites rchites Dec 10, 2014 8:22 AM Flag

    I think he is stinky the chimp doing more then one liners. trembleay is to stupid to understand the company has research and development cost do to the different platforms. He is to stupid to even check if institutions and funds own the stock before posting nobody owns it................... MONKEYBRAIN also.

  • Reply to

    hey pat tremblay..

    by starteam003 Dec 9, 2014 10:02 PM
    rchites rchites Dec 10, 2014 8:12 AM Flag

    Vanguard Group Inc.
    09/30/2014
    Geode Capital Management LLC
    09/30/2014
    KCG Holdings Inc.
    09/30/2014
    IBIO 97,702 $60 09/30/2014
    Northern Trust Corp
    09/30/2014
    IBIO 38,976 $24 09/30/2014
    GW Henssler & Associates Ltd.
    09/30/2014
    IBIO 17,500 $11 09/30/2014
    State Street Corp
    09/30/2014
    IBIO 13,400 $8 09/30/2014
    Thompson Davis & CO. Inc.
    09/30/2014
    IBIO 5,000 $3 09/30/2014
    UBS AG

  • Reply to

    hey pat tremblay..

    by starteam003 Dec 9, 2014 10:02 PM
    rchites rchites Dec 10, 2014 7:55 AM Flag

    THESE can and most have been adding monkeybrain............. LARGEST holders are ASPIRE and Eastern Capital
    Vanguard Extended Market Index Fund, Vanguard Total Stock Market Index Fund Vanguard Total Stock Market Index Fund Fidelity Spartan Extended Market Index Fund Vanguard Invt. Fds. ICVC - US Equity Index
    KCG Americas LLC
    Northern Trust Investments, Inc.
    G. W. Henssler & Associates Ltd.
    Millennium Management LLC
    SSgA Funds Management, Inc.
    Thompson, Davis & Co.
    UBS Financial Services, Inc.

    What kind of monkey brain are you.

CLNT
3.41+0.12(+3.49%)Dec 26 3:57 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST